Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy.

Abstract excerpt

A long-term goal of pharmacogenomics research is the design of individualized therapy based on the genomic sequence of the patient, in order to maximize response and minimize adverse drug reactions. Pharmacoethnicity, or ethnic diversity in drug response or toxicity, is becoming increasingly recognized as an important factor accounting for interindividual variation in anticancer drug responsiveness. Although...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anthracyclines
• Share to Antimetabolites, Antineoplastic